Clinical development of Enzyme Replacement Therapy in alpha-Mannosidosis patients using recombinant human enzyme

Project Information

ALPHA-MAN

Grant agreement ID: 261331

Project closed

Start date 1 October 2010

End date 31 March 2014

Funded under

• Specific Programme "Cooperation": Health

Total cost € 8 028 469,20

EU contribution € 5 887 150,00

Coordinated by

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
Germany

• Replacing an enzyme to control a very rare disease
  EN